Greenwich Stock Future Price Prediction

GLSI -  USA Stock  

USD 8.66  0.24  2.70%

Greenwich Lifesciences stock price prediction is an act of determining the future value of Greenwich Lifesciences shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Greenwich Lifesciences' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Greenwich Lifesciences and does not consider all of the tangible or intangible factors available from Greenwich Lifesciences' fundamental data. We analyze noise-free headlines and recent hype associated with Greenwich Lifesciences, which may create opportunities for some arbitrage if properly timed.
Please check Greenwich Lifesciences Basic Forecasting Models to cross-verify your projections.
  
Refresh
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Greenwich Lifesciences based on different types of headlines from major news networks to social media. The Greenwich stock price prediction module provides an analysis of price elasticity to changes in media outlook on Greenwich Lifesciences over a specific investment horizon. Using Greenwich Lifesciences hype-based prediction, you can estimate the value of Greenwich Lifesciences from the perspective of Greenwich Lifesciences response to recently generated media hype and the effects of current headlines on its competitors.
Greenwich Lifesciences Debt to Equity Ratio is most likely to increase slightly in the upcoming years. The last year's value of Debt to Equity Ratio was reported at 0.014
This module is based on analyzing investor sentiment around taking a position in Greenwich Lifesciences. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Greenwich Lifesciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Greenwich because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Greenwich Lifesciences after-hype prediction price

    
  $ 10.06  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Greenwich Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Greenwich Lifesciences in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
1.3025.9175.20
Details
Naive
Forecast
LowNext ValueHigh
0.073.7453.03
Details
1 Analysts
Consensus
LowTarget PriceHigh
78.0078.0078.00
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
9.5917.9826.36
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Greenwich Lifesciences. Your research has to be compared to or analyzed against Greenwich Lifesciences' peers to derive any actionable benefits. When done correctly, Greenwich Lifesciences' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Greenwich Lifesciences.

Greenwich Lifesciences After-Hype Price Prediction Density Analysis

As far as predicting the price of Greenwich Lifesciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Greenwich Lifesciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Greenwich Lifesciences, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Greenwich Lifesciences Estimiated After-Hype Price Volatility

In the context of predicting Greenwich Lifesciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Greenwich Lifesciences' historical news coverage. Greenwich Lifesciences' after-hype downside and upside margins for the prediction period are 0.50 and 59.35, respectively. We have considered Greenwich Lifesciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 8.66
10.06
After-hype Price
59.35
Upside
Greenwich Lifesciences is very risky asset. Analysis and calculation of next after-hype price of Greenwich Lifesciences is based on 3 months time horizon.

Greenwich Lifesciences Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Greenwich Lifesciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Greenwich Lifesciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Greenwich Lifesciences, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
  1.09  4.60   1.14   0.21  4 Events / Month1 Events / MonthIn about 4 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
8.6610.0616.17 
438.10  

Greenwich Lifesciences Hype Timeline

Greenwich Lifesciences is currently traded for 8.66. The entity has historical hype elasticity of -1.14 and average elasticity to hype of competition of 0.21. Greenwich is projected to increase in value after the next headline with price projected to jump to 10.06 or above. The average volatility of media hype impact on the company stock price is over 100%. The price rise on the next news is forecasted to be 16.17% whereas the daily expected return is currently at -1.09%. The volatility of related hype on Greenwich Lifesciences is about 2421.05% with expected price after next announcement by competition of 8.87. The company currently holds 635.15 K in liabilities. Greenwich Lifesciences has a current ratio of 69.22, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Greenwich Lifesciences until it has trouble settling it off, either with new capital or with free cash flow. So, Greenwich Lifesciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Greenwich Lifesciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Greenwich to invest in growth at high rates of return. When we think about Greenwich Lifesciences' use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next projectedpress releasewill be in about 4 days.
Please check Greenwich Lifesciences Basic Forecasting Models to cross-verify your projections.

Greenwich Lifesciences Related Hype Analysis

Having access to credible news sources related to Greenwich Lifesciences' direct competition is more important than ever and may enhance your ability to predict Greenwich Lifesciences' future price movements. Getting to know how Greenwich Lifesciences rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Greenwich Lifesciences may potentially react to the hype associated with one of its peers.

Greenwich Lifesciences Additional Predictive Modules

Most predictive techniques to examine Greenwich price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Greenwich using various technical indicators. When you analyze Greenwich charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Greenwich Lifesciences Predictive Indicators

The successful prediction of Greenwich Lifesciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Greenwich Lifesciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Greenwich Lifesciences based on analysis of Greenwich Lifesciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Greenwich Lifesciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Greenwich Lifesciences's related companies.

Story Coverage note for Greenwich Lifesciences

The number of cover stories for Greenwich Lifesciences depends on current market conditions and Greenwich Lifesciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Greenwich Lifesciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Greenwich Lifesciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Greenwich Lifesciences Short Properties

Greenwich Lifesciences' future price predictability will typically decrease when Greenwich Lifesciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Greenwich Lifesciences often depends not only on the future outlook of the potential Greenwich Lifesciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Greenwich Lifesciences' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out2.30%
Short Percent Of Float8.01%
Float Shares2.9M
Shares Short Prior Month319.52k
Average Daily Volume Last 10 Day113.49k
Average Daily Volume In Three Month69.05k
Date Short Interest29th of April 2022
Please check Greenwich Lifesciences Basic Forecasting Models to cross-verify your projections. Note that the Greenwich Lifesciences information on this page should be used as a complementary analysis to other Greenwich Lifesciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Greenwich Stock analysis

When running Greenwich Lifesciences price analysis, check to measure Greenwich Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Greenwich Lifesciences is operating at the current time. Most of Greenwich Lifesciences' value examination focuses on studying past and present price action to predict the probability of Greenwich Lifesciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Greenwich Lifesciences' price. Additionally, you may evaluate how the addition of Greenwich Lifesciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Is Greenwich Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich Lifesciences. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Greenwich Lifesciences is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Greenwich Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich Lifesciences' market value can be influenced by many factors that don't directly affect Greenwich Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Greenwich Lifesciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.